Page last updated: 2024-09-05

erlotinib hydrochloride and Nephrotic Syndrome

erlotinib hydrochloride has been researched along with Nephrotic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bou Matar, RN; Klein, JD; Sands, JM	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Nephrotic Syndrome

Article	Year
Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats. PloS one, 2013, Volume: 8, Issue:1 Topics: Animals; Antibiotics, Antineoplastic; Aquaporin 2; Creatinine; Doxorubicin; Epithelial Sodium Channels; ErbB Receptors; Erlotinib Hydrochloride; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Male; Nephrotic Syndrome; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Rats; Renal Insufficiency; Sodium Chloride Symporters; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1	2013

Article

Year

Erlotinib preserves renal function and prevents salt retention in doxorubicin treated nephrotic rats.

PloS one, 2013, Volume: 8, Issue:1

Topics: Animals; Antibiotics, Antineoplastic; Aquaporin 2; Creatinine; Doxorubicin; Epithelial Sodium Channels; ErbB Receptors; Erlotinib Hydrochloride; Heparin-binding EGF-like Growth Factor; Humans; Intercellular Signaling Peptides and Proteins; Male; Nephrotic Syndrome; Protein Kinase Inhibitors; Proteinuria; Quinazolines; Rats; Renal Insufficiency; Sodium Chloride Symporters; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1

2013